科研工作:

近三年代表性论文：[1] Yang Debin, Wang Tingfang, Su Zhigui*, Xue Lingjing, Mo Ran, and Zhang Can*. Reversing cancer multidrug resistance in xenograft models via orchestrating multiple actions of functional mesoporous silica nanoparticles. ACS Appl. Mater. Interfaces,2016, 8,22431−22441.(IF 7.145 )[2] Su Zhigui, Chen Minglei, Xiao Yanyu, Sun Minjie, Zong Li, Asghar Sajid, Dong Mei, Li Huipeng, Ping Qineng, Zhang Can. ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance. J Control Release,2014,196:370-383. (IF 7.261)[3] Su Zhigui, Xing Lei, Chen Yinan, Xu Yurui, Yang Feifei, Zhang Can, Ping Qineng, Xiao Yanyu. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharm,2014,11(6):1823-1834. (IF 4.384)[4] Su Zhigui, Shi Yongping, Xiao Yanyu, Sun Minjie, Ping Qineng, Zong Li, Li Sai, Niu Jiangxiu, Huang Aiwen, You Weiliang, Chen Yinan, Chen Xi, Fei Jia, Tian Jia. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization. Int J Pharm,2013,447(1-2):281-292. (IF 3.458)